#VisualAbstract: Sodium–Glucose Co-Transporter-2 (SGLT2) Inhibitors Do Not Improve Survival Free of Organ Support in COVID-19
Click here to read this study in the Lancet. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be ...
Tag: Coronavirus disease 2019
Rapid antigen tests are most effective when used multiple times to detect SARS-CoV-2 infection
1. In this prospective cohort study, rapid coronavirus disease 2019 (COVID-19) antigen tests had optimal performance when asymptomatic participants were ...
Nirmatrelvir-ritonavir is effective in reducing COVID-19-related hospitalization
1. In this retrospective cohort study, nirmatrelvir-ritonavir was effective in reducing 30-day hospitalization and mortality associated with coronavirus disease 2019 ...
Early monoclonal antibody treatment associated with a reduced risk of COVID-19 hospitalization
1. In this propensity score–matched cohort study, early treatment with monoclonal antibodies for outpatients with coronavirus disease 2019 (COVID-19) was ...
Surveillance testing of staff at nursing facilities reduces resident COVID-19 mortality
1. In this retrospective cohort study, a greater volume of coronavirus 2019 (COVID-19) testing of staff members in skilled nursing ...
Molnupiravir and nirmatrelvir-ritonavir reduce COVID-19 mortality in hospitalized patients
1. In this trial emulation study, molnupiravir and nirmatrelvir-ritonavir reduced all-cause mortality in vaccinated and unvaccinated hospitalized patients with coronavirus ...
Symptom and viral relapse more common in COVID-19 patients without antiviral treatment
1. In this retrospective analysis, symptom and viral rebound occurred in almost one-third of coronavirus disease 2019 (COVID-19) patients that ...
Pegylated interferon lambda reduces the risk of COVID-19-related hospitalization
1. In this randomized control trial, pegylated interferon lambda reduced the risk of coronavirus disease 2019 (COVID-19)-related hospitalization as compared ...
VV116 noninferior to nirmatrelvir-ritonavir for sustained recovery in COVID-19 patients
1. VV116 is noninferior compared to nirmatrelvir-ritonavir for achieving sustained recovery in mild-to-moderate coronavirus disease 2019 (COVID-19) cases. 2. Participants ...
Medical masks do not demonstrate definitive noninferiority to N95 respirators in preventing COVID-19
1. This randomized controlled trial did not definitively demonstrate noninferiority between N95 respirators and medical masks in preventing coronavirus disease ...